tirzepatide class action in dallas Zepbound Lawsuit [2026 Update] Mounjaro Lawsuit | July 2026

Tirzepatide is administered as a once-weekly subcutaneous injection, with doses ranging from 2.5 mg to 15 mg depending on the indication and patient tolerance

Jan 8: Astellas has failed to gain approval for what would be the first approved therapy targeting claudin 18.2 (CLDN18.2), a transmembrane protein expressed on the surface of gastric epithelial cancer cells

Incorrect use can lead to significant side effects

E., Kirkpatrick C., Maki K

the relevance of this finding to humans remains uncertain, and UK SmPCs for licensed GLP-1 analogues note this as a precautionary concern rather than a confirmed human risk [6] Sermorelin's risks include fluid retention, joint discomfort, and potential stimulation of pre-existing growth-dependent pathologies

Dyslipidemia in T2DM also contributes to retinal lipid peroxidation, with oxidized low-density lipoprotein (ox-LDL) promoting macrophage infiltration and vascular leakage (79, 80)